(S)-3,3,3-trifluoro-2-phenylpropane-1,2-diol | 52356-12-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (S)-3,3,3-trifluoro-2-phenylpropane-1,2-diol
• 英文别名: 1,2-Propanediol, 3,3,3-trifluoro-2-phenyl-, (2S)-；(2S)-3,3,3-trifluoro-2-phenylpropane-1,2-diol
• CAS: 52356-12-4
• 化学式: C₉H₉F₃O₂
• 分子量: 206.164
• InChiKey: KYVYURDQRMJYHE-MRVPVSSYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (S)-3,3,3-trifluoro-2-phenylpropane-1,2-diol 在 4-二甲氨基吡啶 、 potassium tert-butylate 、 三乙胺 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 反应 14.0h， 生成 (S)-3-(tert-butyldimethylsilyloxy)-1,1,1-trifluoro-2-methoxy-2-phenylpropane
  参考文献：
  名称：

  Enantioselective synthesis of arylmethoxyacetic acid derivatives

  摘要：

  The preparation of several arylmethoxyacetic acids by a sequence of asymmetric dihydroxylation and further oxidation of the resulting glycol with TEMPO/NaClO/NaClO2 is described. The scope and limitations of the reaction are discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(03)00023-5
• 作为产物：
  描述：

  3-(三氟甲基)苯乙烯 在 AD-mix-α 作用下， 以 水 、 叔丁醇 为溶剂， 反应 2.0h， 以98%的产率得到(S)-3,3,3-trifluoro-2-phenylpropane-1,2-diol
  参考文献：
  名称：

  Enantioselective synthesis of arylmethoxyacetic acid derivatives

  摘要：

  The preparation of several arylmethoxyacetic acids by a sequence of asymmetric dihydroxylation and further oxidation of the resulting glycol with TEMPO/NaClO/NaClO2 is described. The scope and limitations of the reaction are discussed. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(03)00023-5

文献信息

• [EN] HETEROCYCLIC DERIVATIVES AS PI3K INHIBITORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES UTILISÉS COMME INHIBITEURS DE PI3K
  申请人：INCYTE CORP

  公开号：WO2020102150A1

  公开（公告）日：2020-05-22

  This application relates to compounds of the following Formula: or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  这项申请涉及以下化合物的公式，或其药用盐，这些化合物是PI3K-γ的抑制剂，可用于治疗自身免疫疾病、癌症、心血管疾病和神经退行性疾病。
• AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
  申请人：Incyte Corporation

  公开号：US20190276435A1

  公开（公告）日：2019-09-12

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  这项申请涉及到化合物的公式（I）或其药用盐，这些化合物是PI3K-γ的抑制剂，可用于治疗自身免疫性疾病、癌症、心血管疾病和神经退行性疾病。
• Palladium-Catalyzed Negishi Coupling of α-CF₃ Oxiranyl Zincate: Access to Chiral CF₃-Substituted Benzylic Tertiary Alcohols
  作者：Hu Zhang、Stephen L. Buchwald

  DOI：10.1021/jacs.7b06630

  日期：2017.8.23

  We report a Pd-catalyzed stereospecific α-arylation of optically pure 2,3-epoxy-1,1,1-trifluoropropane (TFPO). This method allows for the direct and reliable preparation of optically pure 2-CF3-2-(hetero)aryloxiranes, which are precursors to many CF3-substituted tertiary alcohols. The use of continuous-flow methods has allowed the deprotonation of TFPO and subsequent zincation at higher temperature

  我们报告了 Pd 催化的光学纯 2,3-环氧-1,1,1-三氟丙烷 (TFPO) 的立体定向 α-芳基化。这种方法允许直接和可靠地制备光学纯的 2-CF3-2-（杂）芳基环氧乙烷，它是许多 CF3 取代的叔醇的前体。与传统分批条件相比，连续流动方法的使用允许 TFPO 去质子化和随后在更高温度下锌化。
• Tertiary alcohols as PI3K-γ inhibitors
  申请人：Incyte Corporation

  公开号：US10738057B2

  公开（公告）日：2020-08-11

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本申请涉及式 (I) 化合物： 或其药学上可接受的盐，它们是 PI3K-γ 的抑制剂，可用于治疗自身免疫性疾病、癌症、心血管疾病和神经退行性疾病等疾病。
• Aminopyrazine diol compounds as PI3K-γ inhibitors
  申请人：Incyte Corporation

  公开号：US10669262B2

  公开（公告）日：2020-06-02

  This application relates to compounds of Formula (I): or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.

  本申请涉及式（I）化合物或其药学上可接受的盐，它们是 PI3K-γ 的抑制剂，可用于治疗自身免疫性疾病、癌症、心血管疾病和神经退行性疾病等疾病。